Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Shikami M

Collect these papers and discover other ones on Labmeeting. Learn more.

Growth inhibition of AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for vascular endothelial growth factor.

+ cite this

+ View Abstract

Imai N, Miwa H, Shikami M, Suganuma K, Gotoh M, Hiramatsu A, Wakabayashi M, Watarai M, Hanamura I, Imamura A, Mihara H, Shitara K, Shibuya M, and Nitta M

Leukemia research 33(12):1650-7, 2009 Dec - Who cited this? | PubMed ID: 19342098 | Fulltext

Cyclin-dependent kinase 1 inhibitor RO-3306 enhances p53-mediated Bax activation and mitochondrial apoptosis in AML.

+ cite this

+ View Abstract

Kojima K, Shimanuki M, Shikami M, Andreeff M, and Nakakuma H

Cancer science 100(6):1128-36, 2009 Jun - Who cited this? | PubMed ID: 19385969 | Fulltext

The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML.

+ cite this

+ View Abstract

Kojima K, Shimanuki M, Shikami M, Samudio IJ, Ruvolo V, Corn P, Hanaoka N, Konopleva M, Andreeff M, and Nakakuma H

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 2008 Jun 12 - Who cited this? | PubMed ID: 18548093 | Fulltext

Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis.

+ cite this

+ View Abstract

Nakase K, Kita K, Miwa H, Nishii K, Shikami M, Tanaka I, Tsutani H, Ueda T, Nasu K, Kyo T, Dohy H, Shiku H, and Katayama N

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 21(2):326-32, 2007 Feb - Who cited this? | PubMed ID: 17205058 | Fulltext

t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt.

+ cite this

+ View Abstract

Imai N, Shikami M, Miwa H, Suganuma K, Hiramatsu A, Watarai M, Satoh A, Itoh M, Imamura A, Mihara H, and Nitta M

British journal of haematology 135(5):673-82, 2006 Dec - Who cited this? | PubMed ID: 17107349 | Fulltext

Gene expression changes in a patient presenting nonleukaemic nasal granulocytic sarcoma to acute myelogenous leukaemia using 40 K cDNA microarray.

+ cite this

+ View Abstract

Teramoto H, Miwa H, Patel V, Letwin N, Castellone MD, Imai N, Shikami M, Imamura A, Gutkind JS, Nitta M, and Lee NH

Clinical and laboratory haematology 28(4):262-6, 2006 Aug - Who cited this? | PubMed ID: 16898967 | Fulltext

Low p53 expression of acute myelocytic leukemia cells with t(8;21) chromosome abnormality: association with low p14(ARF) expression.

+ cite this

+ View Abstract

Shikami M, Miwa H, Nishii K, Kyo T, Tanaka I, Shiku H, Kita K, and Nitta M

Leukemia research 30(4):379-83, 2006 Apr - Who cited this? | PubMed ID: 16162359 | Fulltext

Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML.

+ cite this

+ View Abstract

Hiramatsu A, Miwa H, Shikami M, Ikai T, Tajima E, Yamamoto H, Imai N, Hattori A, Kyo T, Watarai M, Miura K, Satoh A, Itoh M, Imamura A, Mihara H, Katoh Y,

(show remaining authors)

Leukemia & lymphoma 47(1):89-95, 2006 Jan - Who cited this? | PubMed ID: 16465716 | Fulltext

MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy.

+ cite this

+ View Abstract

Kojima K, Konopleva M, Samudio IJ, Shikami M, Cabreira-Hansen M, McQueen T, Ruvolo V, Tsao T, Zeng Z, Vassilev LT, and Andreeff M

Blood 106(9):3150-9, 2005 Nov 1 - Who cited this? | PubMed ID: 16014563 | Fulltext

Placenta growth factor stimulates the growth of Philadelphia chromosome positive acute lymphoblastic leukemia cells by both autocrine and paracrine pathways.

+ cite this

+ View Abstract

Ikai T, Miwa H, Shikami M, Hiramatsu A, Tajima E, Yamamoto H, Imai N, Hattori A, Nishii K, Miura K, Satoh A, Itoh M, Imamura A, Mihara H, Katoh Y, and Nitta M

European journal of haematology 75(4):273-9, 2005 Oct - Who cited this? | PubMed ID: 16146532 | Fulltext

Acute promyelocytic leukemia with drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection.

+ cite this

+ View Abstract

Satoh A, Ikai T, Miwa H, Imai N, Hiramatsu A, Tajima E, Yamamoto H, Wakabayashi M, Miura K, Ito M, Shikami M, Imamura A, Mihara H, Kato Y, and Nitta M

Internal medicine (Tokyo, Japan) 43(1):74-8, 2004 Jan - Who cited this? | PubMed ID: 14964584 | Fulltext

Autocrine pathway of angiopoietins-Tie2 system in AML cells: association with phosphatidyl-inositol 3 kinase.

+ cite this

+ View Abstract

Wakabayashi M, Miwa H, Shikami M, Hiramatsu A, Ikai T, Tajima E, Yamamoto H, Miura K, Satoh A, Itoh M, Imamura A, Mihara H, Katoh Y, and Nitta M

The hematology journal : the official journal of the European Haematology Association / EHA 5(4):353-60, 2004 - Who cited this? | PubMed ID: 15297853 | Fulltext

Aplastic anaemia associated with a Philadelphia chromosome and monosomy 7 during immunosuppressive therapy.

+ cite this

+ View Abstract

Satoh A, Miwa H, Daimaru O, Imai N, Hiramatsu A, Yamamoto H, Shikami M, Imamura A, Mihara H, and Nitta M

European journal of haematology 71(2):130-2, 2003 Aug - Who cited this? | PubMed ID: 12890154 | Fulltext

Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.

+ cite this

+ View Abstract

Nishii K, Katayama N, Miwa H, Shikami M, Usui E, Masuya M, Araki H, Lorenzo F, Ogawa T, Kyo T, Nasu K, Shiku H, and Kita K

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 16(7):1285-92, 2002 Jul - Who cited this? | PubMed ID: 12094252 | Fulltext

Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.

+ cite this

+ View Abstract

Tokura Y, Shikami M, Miwa H, Watarai M, Sugamura K, Wakabayashi M, Satoh A, Imamura A, Mihara H, Katoh Y, Kita K, and Nitta M

Leukemia research 26(1):29-36, 2002 Jan - Who cited this? | PubMed ID: 11734301 | Fulltext

Expression of endothelial cell-associated molecules in AML cells.

+ cite this

+ View Abstract

Watarai M, Miwa H, Shikami M, Sugamura K, Wakabayashi M, Satoh A, Tsuboi K, Imamura A, Mihara H, Katoh Y, Kita K, and Nitta M

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 16(1):112-9, 2002 Jan - Who cited this? | PubMed ID: 11840270 | Fulltext

Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.

+ cite this

+ View Abstract

Nishii K, Kita K, Miwa H, Shikami M, Taniguchi M, Usui E, Katayama N, and Shiku H

International journal of hematology 71(4):372-8, 2000 Jun - Who cited this? | PubMed ID: 10905058 | Fulltext

Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: association with the expression of bcl-2 protein.

+ cite this

+ View Abstract

Nishii K, Katayama N, Miwa H, Shikami M, Masuya M, Shiku H, and Kita K

British journal of haematology 105(3):701-10, 1999 Jun - Who cited this? | PubMed ID: 10354135 | Fulltext

Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin-2 receptor alpha chain.

+ cite this

+ View Abstract

Shikami M, Miwa H, Nishii K, Takahashi T, Shiku H, Tsutani H, Oka K, Hamaguchi H, Kyo T, Tanaka K, Kamada N, and Kita K

British journal of haematology 105(3):711-9, 1999 Jun - Who cited this? | PubMed ID: 10354136 | Fulltext

Low BCL-2 expression in acute leukemia with t(8;21) chromosomal abnormality.

+ cite this

+ View Abstract

Shikami M, Miwa H, Nishii K, Takahashi T, Sekine T, Mahmud N, Nishikawa M, Shiku H, Kamada N, and Kita K

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 13(3):358-68, 1999 Mar - Who cited this? | PubMed ID: 10086726 | Fulltext

Frequent expression of human Thy-1 antigen on pre-B cell acute lymphoblastic leukemia with t(9;22).

+ cite this

+ View Abstract

Takahashi T, Mizutani M, Miwa H, Katayama N, Nishii K, Shikami M, Yamaguchi M, Shiku H, Kamada N, and Kita K

International journal of hematology 67(4):369-78, 1998 Jun - Who cited this? | PubMed ID: 9695410 | Fulltext

Biphasic expression of CD4 in acute myelocytic leukemia (AML) cells: AML of monocyte origin and hematopoietic precursor cell origin.

+ cite this

+ View Abstract

Miwa H, Mizutani M, Mahmud N, Yamaguchi M, Takahashi T, Shikami M, Shiku H, Tanaka I, Nakase K, Nasu K, Dohy H, Ueda T, Kamada N, and Kita K

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 12(1):44-51, 1998 Jan - Who cited this? | PubMed ID: 9436919 | Fulltext

Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.

+ cite this

+ View Abstract

Mizutani M, Miwa H, Takahashi T, Katoh K, Shikami M, Katayama N, Shiku H, and Kita K

International journal of hematology 66(4):479-91, 1997 Dec - Who cited this? | PubMed ID: 9479874 | Fulltext

[An autopsy care of hemophagocytic syndrome associated with miliary tuberculosis].

+ cite this

+ View Abstract

Morita K, Shikami M, Nishii Y, Ueno T, and Yamaguchi T

[Rinsho ketsueki] The Japanese journal of clinical hematology 36(2):153-5, 1995 Feb - Who cited this? | PubMed ID: 7715087 | Fulltext

Search Google Scholar for Shikami M

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!